Health law and policy in the European Union.
ABSTRACT From its origins as six western European countries coming together to reduce trade barriers, the European Union (EU) has expanded, both geographically and in the scope of its actions, to become an important supranational body whose policies affect almost all aspects of the lives of its citizens. This influence extends to health and health services. The EU's formal responsibilities in health and health services are limited in scope, but, it has substantial indirect influence on them. In this paper, we describe the institutions of the EU, its legislative process, and the nature of European law as it affects free movement of the goods, people, and services that affect health or are necessary to deliver health care. We show how the influence of the EU goes far beyond the activities that are most visible to health professionals, such as research funding and public health programmes, and involves an extensive body of legislation that affects almost every aspect of health and health care.
SourceAvailable from: Pier Sergio Saba[Show abstract] [Hide abstract]
ABSTRACT: Medici Diabetologi (AMD), Associazione Italiana Aritmia e Cardiostimolazione (AIAC), Società Italiana dell'Obesità (SIO), Societa' Italiana di Prevenzione Cardiovascolare (SIPREC) and Osservatorio Nazionale della Sanità Elettronica e Telemedicina (ONSET) Objectives To review information on cardiovascular health and migration, to stress the attention of researchers that much needs to be done in the collection of sound data in Italy and to allow policy-makers to identify this issue as an important public health concern. Background In Italy, the rate of immigrants in the total number of residents increased from 2.5% in 1990 to 7.4% in 2010, and currently exceeds 10% in regions such as Lombardia, Emilia Romagna and Toscana.Journal of Cardiovascular Medicine 08/2014; 15:683. DOI:10.2459/JCM.0000000000000069 · 1.41 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Chronic kidney disease (CKD) is an important global public health problem that is associated with adverse health outcomes and high health care costs. Effective and cost-effective treatments are available for slowing the progression of CKD and preventing its complications, including cardiovascular disease. Although wealthy nations have highly structured schemes in place to support the care of people with kidney failure, less consideration has been given to health systems and policy for the much larger population of people with non-dialysis-dependent CKD. Further, how to integrate such strategies with national and international initiatives for control of other chronic noncommunicable diseases (NCDs) merits attention. We synthesized the various approaches to CKD control across 17 European countries and present our findings according to the key domains suggested by the World Health Organization framework for NCD control. This report identifies opportunities to strengthen CKD-relevant health systems and explores potential mechanisms to capitalize on these opportunities. Across the 17 countries studied, we found a number of common barriers to the care of people with non-dialysis-dependent CKD: limited work force capacity, the nearly complete absence of mechanisms for disease surveillance, lack of a coordinated CKD care strategy, poor integration of CKD care with other NCD control initiatives, and low awareness of the significance of CKD. These common challenges faced by diverse health systems reflect the need for international cooperation to strengthen health systems and policies for CKD care. Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.American Journal of Kidney Diseases 11/2014; 65(1). DOI:10.1053/j.ajkd.2014.07.033 · 5.76 Impact Factor
Article: Psephology and pulmonologyEuropean Respiratory Journal 09/2014; 44(3):589-91. DOI:10.1183/09031936.00104014 · 7.13 Impact Factor